Literature DB >> 16188400

Predisposing conditions and risk factors for development of symptomatic meningioma in adults.

Brigitte Schneider1, Heinke Pülhorn, Bernd Röhrig, Nikolai G Rainov.   

Abstract

BACKGROUND: Risk factors and predisposing factors for the development of symptomatic meningioma during adult life are not well known.
METHODS: Data from 306 consecutive patients with primary meningioma were collected retrospectively in a hypothesis-generating study. Factors studied included localisation of tumours, blood group typing, and risk factors, such as diabetes mellitus, coronary arterial disease, hypertension, rheumatoid arthritis, bronchial asthma, smoking, obesity, and second primary tumour. Case-control analysis of putative risk factors was carried out using a control data set from the German East-West Health Survey (n=7466, age range 25-69 years). Patients and controls were matched for age, gender, geographic area, and time of data collection.
RESULTS: Rh(D) positive cases were significantly less frequent in the patient group compared to controls (p=0.01). Pre-existing diabetes was associated with meningioma in middle-aged (40-69 years) patients (odds ratio, OR 13.94-4.30, p=0.001-0.05). In female patients, arterial hypertension was significantly associated with occurrence of meningioma in the age group 60-69 years (OR=2.23, p=0.041). Rheumatoid arthritis had a negative association with meningioma in both males and females in the age groups above 50 years (OR 0.19-0.27, p=0.02-0.034). Bronchial asthma, smoking, and obesity were not significantly associated with meningioma. A second primary tumour was present in 12 cases. The most frequent combination was meningioma and breast cancer (5/12).
CONCLUSIONS: This study shows statistically significant association of some co-morbidities with symptomatic meningioma in adults. Areas of interest have been identified where further research would be necessary.

Entities:  

Mesh:

Year:  2005        PMID: 16188400     DOI: 10.1016/j.cdp.2005.07.002

Source DB:  PubMed          Journal:  Cancer Detect Prev        ISSN: 0361-090X


  19 in total

Review 1.  Advances in meningioma genetics: novel therapeutic opportunities.

Authors:  Matthias Preusser; Priscilla K Brastianos; Christian Mawrin
Journal:  Nat Rev Neurol       Date:  2018-01-05       Impact factor: 42.937

2.  Possible interaction between ionizing radiation, smoking, and gender in the causation of meningioma.

Authors:  Pazit Flint-Richter; Lori Mandelzweig; Bernice Oberman; Siegal Sadetzki
Journal:  Neuro Oncol       Date:  2011-03       Impact factor: 12.300

Review 3.  [Molecular biology, diagnosis, and therapy of meningiomas].

Authors:  C Mawrin
Journal:  Pathologe       Date:  2019-09       Impact factor: 1.011

4.  A case of cervical spine meningioma following etanercept use in a patient with RA.

Authors:  Omer N Pamuk; Ferda Harmandar
Journal:  Nat Rev Rheumatol       Date:  2009-08       Impact factor: 20.543

5.  DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.

Authors:  Francesca Menghi; Francesca N Orzan; Marica Eoli; Mariangela Farinotti; Emanuela Maderna; Federica Pisati; Donatella Bianchessi; Lorella Valletta; Sandro Lodrini; Giuseppe Galli; Elena Anghileri; Serena Pellegatta; Bianca Pollo; Gaetano Finocchiaro
Journal:  Oncologist       Date:  2011-09-23

6.  Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study.

Authors:  Brian Custer; W T Longstreth; Leslie E Phillips; Thomas D Koepsell; Gerald Van Belle
Journal:  BMC Cancer       Date:  2006-06-07       Impact factor: 4.430

7.  Overweight, obesity and meningioma risk: a meta-analysis.

Authors:  Chuan Shao; Li-Ping Bai; Zhen-Yu Qi; Guo-Zhen Hui; Zhong Wang
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240

8.  The effect of weight in the outcomes of meningioma patients.

Authors:  Holly Dickinson; Christine Carico; Miriam Nuño; Kristin Nosova; Adam Elramsisy; Chirag G Patil
Journal:  Surg Neurol Int       Date:  2013-04-03

9.  Lifestyle factors and primary glioma and meningioma tumours in the Million Women Study cohort.

Authors:  V S Benson; K Pirie; J Green; D Casabonne; V Beral
Journal:  Br J Cancer       Date:  2008-06-17       Impact factor: 7.640

10.  Brain tumours and cigarette smoking: analysis of the INTERPHONE Canada case-control study.

Authors:  Stephen Vida; Lesley Richardson; Elisabeth Cardis; Daniel Krewski; Mary McBride; Marie-Elise Parent; Michal Abrahamowicz; Karen Leffondré; Jack Siemiatycki
Journal:  Environ Health       Date:  2014-06-27       Impact factor: 5.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.